SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-060519
Filing Date
2021-05-04
Accepted
2021-05-04 08:07:00
Documents
14
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114997d1_8k.htm   iXBRL 8-K 27534
5 EXHIBIT 99.1 tm2114997d1_ex99-1.htm EX-99.1 56788
6 GRAPHIC tm2114997d1_ex99-1img001.jpg GRAPHIC 10904
  Complete submission text file 0001104659-21-060519.txt   286190

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA knsa-20210504.xsd EX-101.SCH 3184
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20210504_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20210504_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2114997d1_8k_htm.xml XML 3616
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 21886068
SIC: 2834 Pharmaceutical Preparations